Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katy Goyak

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Regulatory Toxicology and Pharmacology : RTP|February 23, 2024
Sensory irritation and use of the best available science in setting exposure limits: Issues raised by a scientific panel review of formaldehyde human research studiesKaty Goyak, Stewart Holm
Critical Reviews in Toxicology|September 9, 2017
Evaluating the MoA/human relevance framework for F-344 rat liver epithelioid granulomas with mineral oil hydrocarbonsDavid Adenuga, Katy Goyak, R Jeffrey Lewis
ALTEX|October 16, 2023
Challenges integrating skin sensitization data for assessment of difficult to test substancesAllison Greminger, Joseph Frasca, Katy Goyak, et al.
Environmental Science & Technology|August 11, 2023
Integrating Concentration-Dependent Toxicity Data and Toxicokinetics To Inform Hepatotoxicity Response PathwaysDaniel P Russo, Lauren M Aleksunes, Katy Goyak, et al.
Regulatory Toxicology and Pharmacology : RTP|January 8, 2013
Use and validation of HT/HC assays to support 21st century toxicity evaluationsGrace Patlewicz, Ted Simon, Katy Goyak, et al.
Regulatory Toxicology and Pharmacology : RTP|June 17, 2024
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendationsManon Beekhuijzen, Emily Richmond, Jason Manton, et al.
Regulatory Toxicology and Pharmacology : RTP|December 24, 2023
The last resort requirement under REACH: From principle to practiceDonna S Macmillan, Anders Bergqvist, Eleanor Burgess-Allen, et al.
ALTEX|April 10, 2021
Applying evidence-based methods to the development and use of adverse outcome pathwaysRob B M De Vries, Michelle Angrish, Patience Browne, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Regulatory Toxicology and Pharmacology : RTP|February 23, 2024
Sensory irritation and use of the best available science in setting exposure limits: Issues raised by a scientific panel review of formaldehyde human research studiesKaty Goyak, Stewart Holm
Critical Reviews in Toxicology|September 9, 2017
Evaluating the MoA/human relevance framework for F-344 rat liver epithelioid granulomas with mineral oil hydrocarbonsDavid Adenuga, Katy Goyak, R Jeffrey Lewis
ALTEX|October 16, 2023
Challenges integrating skin sensitization data for assessment of difficult to test substancesAllison Greminger, Joseph Frasca, Katy Goyak, et al.
Environmental Science & Technology|August 11, 2023
Integrating Concentration-Dependent Toxicity Data and Toxicokinetics To Inform Hepatotoxicity Response PathwaysDaniel P Russo, Lauren M Aleksunes, Katy Goyak, et al.
Regulatory Toxicology and Pharmacology : RTP|January 8, 2013
Use and validation of HT/HC assays to support 21st century toxicity evaluationsGrace Patlewicz, Ted Simon, Katy Goyak, et al.
Regulatory Toxicology and Pharmacology : RTP|June 17, 2024
Review of dose setting for the extended one-generation reproductive toxicity studies (OECD TG 443): Considerations on ECHA's dose level selection recommendationsManon Beekhuijzen, Emily Richmond, Jason Manton, et al.
Regulatory Toxicology and Pharmacology : RTP|December 24, 2023
The last resort requirement under REACH: From principle to practiceDonna S Macmillan, Anders Bergqvist, Eleanor Burgess-Allen, et al.
ALTEX|April 10, 2021
Applying evidence-based methods to the development and use of adverse outcome pathwaysRob B M De Vries, Michelle Angrish, Patience Browne, et al.
Pageof 1